ANMOL PATEL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner CASA GRANDE, AZ NPI 1124873690
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner AZ Lilly USA, LLC All categories
General Payments — all program years on this page
$174.53
- Category: General Payments
- Program years: PY2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $174.53 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.53 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $36.28 | 2 |
| EISAI INC. | $31.73 | 1 |
| ABBVIE INC. | $29.13 | 1 |
| Novo Nordisk AS | $26.66 | 2 |
| DEXCOM, INC. | $19.09 | 1 |
| PFIZER INC. | $17.39 | 1 |
| GlaxoSmithKline, LLC. | $14.25 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $174.53 | 9 |
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100567172 | Novo Nordisk Inc | $13.37 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100575926 | Novo Nordisk Inc | $13.29 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107802700 | ABBVIE INC. | $29.13 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110793483 | Eisai Inc. | $31.73 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116101039 | GlaxoSmithKline, LLC. | $14.25 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131872263 | PFIZER INC. | $17.39 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135503770 | Lilly USA, LLC | $19.39 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135529227 | Lilly USA, LLC | $16.89 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153349208 | Dexcom, Inc. | $19.09 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.